Sionna Therapeutics, Inc.
SION
$35.58
-$0.48-1.33%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | 6.52M | 5.99M | 3.88M | 3.06M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 21.91M | 19.66M | 18.13M | 11.29M | |
| Operating Income | -21.91M | -19.66M | -18.13M | -11.29M | |
| Income Before Tax | -18.07M | -16.48M | -15.85M | -8.55M | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -18.07M | -16.48M | -15.85M | -8.55M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -18.07M | -16.48M | -15.85M | -8.55M | |
| EBIT | -21.91M | -19.66M | -18.13M | -11.29M | |
| EBITDA | -21.76M | -19.50M | -17.97M | -11.13M | |
| EPS Basic | -0.41 | -0.62 | -3.38 | -2.71 | |
| Normalized Basic EPS | -0.26 | -0.39 | -2.11 | -1.69 | |
| EPS Diluted | -0.41 | -0.62 | -3.38 | -2.71 | |
| Normalized Diluted EPS | -0.26 | -0.39 | -2.11 | -1.69 | |
| Average Basic Shares Outstanding | 44.12M | 26.60M | 4.69M | 3.16M | |
| Average Diluted Shares Outstanding | 44.12M | 26.60M | 4.69M | 3.16M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |